Exclusive: Høeg tells FDA staff she'll scrutinize RSV shots and SSRIs in pregnancy

Also: How nicotine got a sleek performance enhancer rebrand, despite the actual science behind the drug ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

February 20, 2026 Check out STAT+

Sponsored By

An ophthalmologist's organ of interest? Solve the latest STAT crossword.

Mike Stewart/AP STAT+ | In first speech to her FDA staff, Høeg says she'll scrutinize RSV shots and SSRIs in pregnancy Tracy Beth Høeg, the top drug regulator at the FDA, plans to question the safety of taking SSRIs in pregnancy and of RSV shots given to infants. By Lizzy Lawrence STAT+ | Opinion: Sometimes, it would be unethical not to use AI in medicine Ignoring proven AI tools in medicine can constitute negligence. But so can blind adherence to algorithmic outputs. By Morish Shah and Ami Bhatt With federal research funding uncertain, states debate new science initiatives With National Institutes of Health funding in flux, states explore financing their own biomedical research efforts. By Anil Oza Adobe Biohackers and wellness influencers are pushing nicotine as part of their 'stacks' From tech offices to fitness influencers, nicotine is being sold as a focus and productivity boost. Experts say addiction and legal risks are being downplayed. By Sarah Todd STAT+ | Key study of Grail's cancer detection test fails in setback for company While Grail's screening test, called Galleri, showed some benefits, the results are likely to fuel more debate about the technology. By Matthew Herper and Angus Chen STAT+ | Texas attorney general sues Sanofi for allegedly providing kickbacks to doctors to prescribe its drugs The lawsuit alleges that Sanofi offers free nurses and insurance support services as an inducement to save physicians time and money. By Ed Silverman Adobe Would you trust AI to renew your drug prescriptions? Doctronic is an AI physician chatbot that can diagnose symptoms and, in Utah at least, refill your prescriptions. STATus Report host Alex Hogan dives in. By Alex Hogan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser